SUPIXA A next-generation oral anticoagulant redefining treatment of non-valvular atrial fibrillation(NVAF) and DVT/PE
Starting on:
Nov 13, 2025
Ending on:
Nov 13, 2025
Moderator(s):
Dr. Jonathan Wala
Nephrologist/Physician
Venue:
NAIROBI SERENA HOTEL
Max Credits:
3 Points

Provider:
Kenya Renal Association
Claim Points

SUPIXA A next-generation oral anticoagulant redefining treatment of non-valvular atrial fibrillation(NVAF) and DVT/PE

Starting on:
Nov 13, 2025
Ending on:
Nov 13, 2025
Venue:
NAIROBI SERENA HOTEL

Description

SUPIXA A next-generation oral anticoagulant redefining treatment of non-valvular atrial fibrillation(NVAF) and DVT/PE

Objectives

SUPIXA A next-generation oral anticoagulant redefining treatment of non-valvular atrial fibrillation(NVAF) and DVT/PE

Presenters

  1. Prof. Ahmed Sokwala
    PHYSICIAN/NEPHROLOGIST
    Agakhan University Hospital

  2. Dr. YUBRINE GACHEMBA
    Cardiologist/Physician
    The Nairobi Hospital

Search For CPD Activity